[1]. Dapagliflozin in Patients with Chronic Kidney Disease.
The New England journal of medicine [巻]384 [号]4 [頁]389 （2021年） [査読] 有
[DOI] [2]. AKIと感染症 (特集 AKI(急性腎障害)Update)
日本内科学会雑誌 日本内科学会 [巻]110 [号]5 [頁]949 -954 （2021年） [査読] 無
[URL] [3]. Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan.
Scientific reports [巻]12 [号]1 [頁]2967 （2022年） [査読] 有
[DOI] [4]. Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association （2022年） [査読] 有
[DOI] [5]. Nicotinic acetylcholine receptor agonist reduces acute lung injury after renal ischemia-reperfusion injury by acting on splenic macrophages in mice.
American journal of physiology. Renal physiology [巻]322 [号]5 [頁]F540 -F552 （2022年） [査読] 有
[DOI]